Biblio
2021
Ji J, Liu Z, Kuang P, Dong T, Chen X, Li J, Zhang C, Liu J, Zhang L, Shen K, et al. A New Conditioning Regimen with Chidamide, Cladribine, Gemcitabine, and Busulfan Significantly Improve the Outcome of High-risk or Relapsed/Refractory non-Hodgkin's Lymphomas. Int J Cancer. 2021.
2020
Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, et al. Nivolumab treatment for relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistocytosis in adults. Blood. 2020.